-
If you purchased shares of KV Pharmaceutical Company, class A and class B stock (NYSE: KV.A and NYSE: KV.B), you might have certain options and should contact the Shareholders Foundation, Inc
-
To have your information reviewed for options and to receive notifications about this case, please send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.
Lawsuit Overview
April 23, 2014 - The court approved the settlement, entered the orders approving the plan of allocation, the motion for attorneys’ fees and expenses, and dismissed the action with prejudice. January 28, 2014 - The court preliminarily approved the settlement. December 20, 2013 - Parties filed a stipulation of settlement. June 24, 2013 - The court granted the dismissal of all claims ...
You must register (for free) or login to view the entire case.
